Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00199966 · ClinicalTrials.gov registry record · Phase 4
Safety And Efficacy Study Of Depakote ER To Treat Pediatric Bipolar Disorder
A Phase 4 study, sponsored by Medical College of Wisconsin.
- Completed
- Registry status
- Phase 4
- Development phase
- 30
- Enrollment target
NCT00199966 is a Phase 4 study that has completed, run by Medical College of Wisconsin. The registered enrollment target is 30 participants.
The verdict
NCT00199966, a Phase 4 study, has completed, sponsored by Medical College of Wisconsin.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 30 participants
- Enrollment target
Study Summary
The purpose of this research is to compare how safely and how well this medicine works in treating children and teenagers between the ages of 6 and 17 years with a diagnosis of Bipolar Disorder.
Interventions
- DRUG Divalproex sodium extended release
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2003-12 |
| Est. Completion | 2005-11 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00199966
The ClinicalTrials.gov registry entry for NCT00199966 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medical College of Wisconsin, which has 447 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Divalproex sodium extended release is the first listed.
NCT00199966 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00199966 about?
NCT00199966 is a clinical study titled "Safety And Efficacy Study Of Depakote ER To Treat Pediatric Bipolar Disorder". The purpose of this research is to compare how safely and how well this medicine works in treating children and teenagers between the ages of 6 and 17 years with a diagnosis of Bipolar Disorder.
What is the current status of trial NCT00199966?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 30 participants. The study started on 2003-12. Estimated completion is 2005-11.
What interventions are being tested in trial NCT00199966?
The interventions under investigation include: Divalproex sodium extended release (DRUG).
Who is sponsoring clinical trial NCT00199966?
This trial is sponsored by Medical College of Wisconsin, which has 447 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.